Effects of an ophthalmic formulation of meloxicam on COX-2 expression, PGE2 release, and cytokine expression in a model of acute ocular inflammation - Concepedia

Concepedia

Publication | Open Access

Effects of an ophthalmic formulation of meloxicam on COX-2 expression, PGE2 release, and cytokine expression in a model of acute ocular inflammation

DOI Full Paper Access

22

Citations

16

References

2007

Year

Raymundo Cruz, Juan D Quintana-Hau, J R Gonzalez, R. Tornero–Montaño, Leopoldo Martín Baiza-Durán, Libia Vega

British Journal of Ophthalmology

Abstract

Meloxicam treatment was more efficient than diclofenac in downregulating the expression and activity of COX-2, reducing inflammation, and modifying the inflammatory-related cytokines.

References

	Year	Citations

Page 1